Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Advertisement intended for health care professionals

Close

ASH Clinical News
ASH News Daily
ASH-SAP
Blood Journals
Hematology
The Hematologist
International
ASH
- ASH Home
- Research
- Education
- Advocacy
- Meetings
- Publications
- ASH Store

header search

search input Search input auto suggest

filter your search

Search

Menu

Issues
- Current Issue
- All Issues
First edition
Abstracts
Collections
Author Center
About

Skip Nav Destination

Update search

Querybuilder input 1 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 2 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 3 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 4 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 5 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 6 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

NARROW

Publications

Filter by publications

Blood (1)

Format

Filter by format

Journal Articles (1)

Article Type

Filter by article-type

Meeting Report (1)

Topics

Filter by topics

atp-binding cassette transporters (1)
bcr-abl tyrosine kinase (1)
blood donors (1)
cytarabine (1)
disease progression (1)
imatinib mesylate (1)
leukemia, myelocytic, chronic (1)
leukemia, myeloid, chronic-phase (1)
leukemic cells (1)
logistic regression (1)

Date

Filter by date

Date range

Single date

From

To

Apply

Availability

Availability

1-1 of 1

Quoc-Hung Lê, MD, PhD

Save search

Follow your search

Access your saved searches in your account

Name your search

Follow this search

Would you like to receive an alert when new items match your search?

Sort by

Sort Order Select

Journal Articles

Pharmacogenomic Factors Such as the Expression of Imatinib Transporters (OCT-1, ABCB-1 and ABCG-2) at Diagnosis, OCT-1 SNPs, and Steady-State Imatinib and Desmethyl-Imatinib Trough Plasma Levels in De Novo Chronic Phase Chronic Myelogenous Leukemia, May Influence Disease Response to Imatinib

Hélène Labussière, MD, Sandrine Hayette, PhD, Kaddour Chabane, BSc, Marie-Claude Gagnieu, PharmD, Quoc-Hung Lê, MD, PhD, Isabelle Tigaud, MD, Joëlle Bernard, BSc, Fiorenza Barraco, MD, Jean-Pierre Magaud, MD, PhD, Mauricette Michallet, MD, PhD, Franck E Nicolini, MD, PhD

Journal: Blood

Blood (2008) 112 (11): 2643.

https://doi.org/10.1182/blood.V112.11.2643.2643

Published: 2008

Advertisement intended for health care professionals

Email alerts

First Edition Alert

Latest Issue Alert

Advertisement intended for health care professionals

Current Issue
First edition
All Issues

Collections
Abstracts
Authors

Submit to Blood
About Blood
Subscriptions

Public Access
Permissions
Alerts

Contact Us
Newsroom
Blood Classifieds

Advertising in Blood
Terms and Conditions
Twitter

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036
TEL +1 202-776-0544
FAX +1 202-776-0545

ASH Publications

Blood
Blood Advances
Blood Global Hematology
Blood Neoplasia
Blood Vessels, Thrombosis & Hemostasis
Hematology, ASH Education Program
ASH Clinical News
ASH-SAP
The Hematologist

American Society of Hematology

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright 2024 by American Society of Hematology

Cookie Settings
Privacy Policy
Cookie Policy
Terms of Use
Contact Us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Advertisement intended for health care professionals